Events
BioXcel Therapeutics, Inc. announced that it will present a late breaking poster featuring data from a preclinical study of the Company’s BXCL701 and an OX40-agonist antibody as a potential combination therapy for treatment of certain solid tumors at the upcoming American Association for Cancer Research Annual Meeting 2019 being held from March 29 to April 3, 2019 in Atlanta, Georgia.
With Cowen & Company’s 39th Annual Health Care Conference going on in Boston this week, a lot of stories in the biopharma industry are coming out. Here are a few highlights.
Ultragenyx Pharmaceutical Inc. today announced that it will present at the following upcoming investor conferences:
These four SMEs will receive a total of over €2 million to finance their projects spanning artificial intelligence in radiology, early diagnosis of cancer, telemedicine for heart failure patients and prediction of acute episodes in cystic fibrosis
AiCuris Anti-infective Cures GmbH is one of three companies nominated for the “Deutscher Innovationspreis 2019” in the category Medium-Sized Enterprises
UAE’s AED 4.40 billion healthcare allocation for 2019 seen to further drive growth in digital healthcare
Visit Booth 2833 to see first-hand, the flexible, configurable FPC60 system at work
Patients, physicians and other healthcare professionals to gather at Hilton Garden Inn April 4 - 6 to help the 171,000 people now living with neuroendocrine (NET) cancer in the U.S.
Event for experts from academia and industry, including talks, live demo sessions, and panel discussion
March 8, 2019, United Kingdom, 2019- GHP Magazine has announced the winners of the 2019 Biotechnology Awards.
PRESS RELEASES